Catherine C Gao1, Ekta Kapoor2,3, Melissa C Lipford4, Virginia M Miller5,6, Darrell R Schroeder7, Kristin C Mara7, Stephanie S Faubion2. 1. Mayo Clinic School of Medicine, Rochester, MN. 2. Women's Health Clinic, Division of General Internal Medicine, Mayo Clinic, Rochester, MN. 3. Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic, Rochester, MN. 4. Center for Sleep Medicine and Department of Neurology, Mayo Clinic, Rochester, MN. 5. Women's Health Research Center, Mayo Clinic, Rochester, MN. 6. Departments of Surgery and Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN. 7. Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
Abstract
OBJECTIVE: The aim of the study was to determine the association between self-reported vasomotor symptoms (VMS) and obstructive sleep apnea (OSA) risk. METHODS: The STOP-BANG to evaluate OSA and Menopause Rating Scale (MRS) were administered to 2,935 women seen in the Women's Health Clinic at Mayo Clinic in Rochester, MN, between May 2015 and December 2016. Of these, 1,691 women were included in the analysis. Total MRS and VMS ratings were compared using logistic regression, with age, smoking, and body mass index (BMI) included as covariates between women at intermediate/high risk versus low risk for OSA. RESULTS: Total MRS scores were significantly higher in women with intermediate/high-risk OSA scores versus those with low-risk scores [mean (SD): 16.8 (8.0) vs 12.9 (7.0), P < 0.001]. Women at intermediate/high OSA risk were older, had more education, self-reported hypertension, BMI >35 kg/m, and were less likely to be married or employed. Self-reported severe/very severe VMS were significantly associated with intermediate/high risk versus low risk for OSA (26.6% vs 15.0%; P < 0.001). After adjusting for age, BMI, smoking status, and self-reported hypertension, the odds of having intermediate/high risk for OSA were 1.87 times higher for those with severe/very severe VMS compared with those with none/mild/moderate VMS (95% CI, 1.29-2.71, P < 0.001). This association persisted upon subgroup analysis based on BMI <25 kg/m (odds ratio 2.15; 95% CI, 1.12-4.16, P = 0.022). CONCLUSIONS: Self-reported severe/very severe VMS were associated with intermediate/high risk for OSA in midlife women, even in women with BMI <25 kg/m. Given the limitations of the STOP-BANG tool, OSA risk may, however, have been overestimated.
OBJECTIVE: The aim of the study was to determine the association between self-reported vasomotor symptoms (VMS) and obstructive sleep apnea (OSA) risk. METHODS: The STOP-BANG to evaluate OSA and Menopause Rating Scale (MRS) were administered to 2,935 women seen in the Women's Health Clinic at Mayo Clinic in Rochester, MN, between May 2015 and December 2016. Of these, 1,691 women were included in the analysis. Total MRS and VMS ratings were compared using logistic regression, with age, smoking, and body mass index (BMI) included as covariates between women at intermediate/high risk versus low risk for OSA. RESULTS: Total MRS scores were significantly higher in women with intermediate/high-risk OSA scores versus those with low-risk scores [mean (SD): 16.8 (8.0) vs 12.9 (7.0), P < 0.001]. Women at intermediate/high OSA risk were older, had more education, self-reported hypertension, BMI >35 kg/m, and were less likely to be married or employed. Self-reported severe/very severe VMS were significantly associated with intermediate/high risk versus low risk for OSA (26.6% vs 15.0%; P < 0.001). After adjusting for age, BMI, smoking status, and self-reported hypertension, the odds of having intermediate/high risk for OSA were 1.87 times higher for those with severe/very severe VMS compared with those with none/mild/moderate VMS (95% CI, 1.29-2.71, P < 0.001). This association persisted upon subgroup analysis based on BMI <25 kg/m (odds ratio 2.15; 95% CI, 1.12-4.16, P = 0.022). CONCLUSIONS: Self-reported severe/very severe VMS were associated with intermediate/high risk for OSA in midlife women, even in women with BMI <25 kg/m. Given the limitations of the STOP-BANG tool, OSA risk may, however, have been overestimated.
Authors: Ellen B Gold; Alicia Colvin; Nancy Avis; Joyce Bromberger; Gail A Greendale; Lynda Powell; Barbara Sternfeld; Karen Matthews Journal: Am J Public Health Date: 2006-05-30 Impact factor: 9.308
Authors: Michael Arzt; Terry Young; Laurel Finn; James B Skatrud; T Douglas Bradley Journal: Am J Respir Crit Care Med Date: 2005-09-01 Impact factor: 21.405
Authors: Dennis Jensen; Larry A Wolfe; Lubomira Slatkovska; Katherine A Webb; Gregory A L Davies; Denis E O'Donnell Journal: Am J Physiol Regul Integr Comp Physiol Date: 2005-01-27 Impact factor: 3.619
Authors: Adeline Tan; Jason D C Yin; Linda W L Tan; Rob M van Dam; Yan Yi Cheung; Chi-Hang Lee Journal: Sleep Med Date: 2016-10-27 Impact factor: 3.492
Authors: Hua Jun Xu; Xiao Fei Lan; Qing Yun Li; Li Na Zhou; Xiu Juan Zhang; Qian Guo; Jin Hua Ni; Bei Cao Journal: Sleep Breath Date: 2014-05-08 Impact factor: 2.816
Authors: Rodrigo P Pedrosa; Isly M L Barros; Luciano F Drager; Marcio S Bittencourt; Ana Kelley L Medeiros; Liana L Carvalho; Thais C Lustosa; Martinha M B Carvalho; Moacir N L Ferreira; Geraldo Lorenzi-Filho; Laura O B F Costa Journal: Chest Date: 2014-07 Impact factor: 9.410
Authors: Virginia M Miller; Juliana M Kling; Julia A Files; Michael J Joyner; Ekta Kapoor; Ann M Moyer; Walter A Rocca; Stephanie S Faubion Journal: Menopause Date: 2018-06 Impact factor: 2.953